−0.0532 SEK
−12.20 M SEK
0.00 SEK
About SPERMOSENS AB
Sector
Industry
CEO
Tore Duvold
Website
Headquarters
Lund
Founded
2018
ISIN
SE0015346424
FIGI
BBG00ZS03VH1
Spermosens AB engages in the research and development of medical device for diagnosing male infertility. It develops a chip that employs sperm-specific receptor proteins of oocyte-origin that binds and induces a biochemical response. The response is then analyzed and determines the viability of the sperm. The company was founded by Kushagr Punyanis and Sudha Srivastavas on October 18, 2018 and is headquartered in Lund, Sweden.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SPERM is 0.0140 SEK — it has decreased by −23.08% in the past 24 hours. Watch SPERMOSENS AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange SPERMOSENS AB stocks are traded under the ticker SPERM.
SPERM stock has risen by 22.81% compared to the previous week, the month change is a 22.81% rise, over the last year SPERMOSENS AB has showed a −97.06% decrease.
SPERM reached its all-time high on Jan 5, 2022 with the price of 27.0000 SEK, and its all-time low was 0.0100 SEK and was reached on Dec 5, 2024. View more price dynamics on SPERM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SPERM stock is 67.74% volatile and has beta coefficient of −0.24. Track SPERMOSENS AB stock price on the chart and check out the list of the most volatile stocks — is SPERMOSENS AB there?
Today SPERMOSENS AB has the market capitalization of 10.61 M, it has increased by 3.33% over the last week.
Yes, you can track SPERMOSENS AB financials in yearly and quarterly reports right on TradingView.
SPERM net income for the last quarter is −2.16 M SEK, while the quarter before that showed −2.37 M SEK of net income which accounts for 8.66% change. Track more SPERMOSENS AB financial stats to get the full picture.
No, SPERM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 7.00 employees. See our rating of the largest employees — is SPERMOSENS AB on this list?
Like other stocks, SPERM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SPERMOSENS AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SPERMOSENS AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SPERMOSENS AB stock shows the sell signal. See more of SPERMOSENS AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.